Common questions about Alphagan (FAQ)
Q: How quickly does Alphagan start to lower eye pressure after the first use?
According to official product information, the pressure-lowering effect of Alphagan begins shortly after application. Official product information notes that the peak pressure-lowering effect in clinical studies typically occurs about two hours after the drop is instilled.
Q: What is the difference between Alphagan P and regular Alphagan?
Both the original Alphagan solution (0.2%) and Alphagan P contain the same active ingredient, brimonidine tartrate. The primary difference lies in the preservative system used. Alphagan P utilizes a preservative called Purite®, whereas the older Alphagan 0.2% uses benzalkonium chloride (BAK).
Q: Is there a generic version of Alphagan available?
Yes, the active ingredient, brimonidine tartrate ophthalmic solution, is available in generic form. The generic versions contain the same active ingredient and are indicated for reducing elevated eye pressure.
Q: Can Alphagan cause changes in the color of the iris (the colored part of the eye)?
Official regulatory documentation for this medication does not list changes in the color of the iris as a reported adverse reaction. While discoloration of the white part of the eye or paleness of the eyelids have been reported in rare cases, iris color change is not among the documented side effects.
Q: Does using Alphagan make you more sensitive to light?
Increased sensitivity to light, known clinically as photophobia, has been reported as a less common side effect in some patients using this medication. Patients are advised to monitor for symptoms of increased light sensitivity while using the medication.
Q: Is it true that Alphagan can make the eye look lighter or bleached?
Official reports do not specifically use the terms 'lighter' or 'bleached' to describe changes in the eye. However, official post-marketing surveillance reports have, in rare cases, included reports of pallor (paleness) of the eyelid or the inner lining of the eye.
Q: What are the most common reasons a doctor would stop prescribing Alphagan?
Based on regulatory documentation summarizing clinical trials, the most frequent reasons noted for patients to stop treatment during clinical studies are often related to certain adverse reactions. These commonly include ocular allergic reactions (such as redness, itching, or burning) and systemic effects like dry mouth or drowsiness.
Q: Are there known food or drink interactions with Alphagan?
Regulatory documents do not mention any specific interactions between Alphagan and food. However, caution is advised regarding alcohol consumption. This is because alcohol may increase the risk of certain side effects, such as central nervous system (CNS) depression, which causes sedation or slowed reflexes.
Q: Can using Alphagan long-term affect my tear production?
Ocular dryness, commonly known as dry eyes, and keratoconjunctivitis sicca (a more severe form of dry eye disease) are listed in official documentation as known adverse reactions from the use of brimonidine.
Q: What should I do if my eye pressure is not decreasing after using Alphagan for a month?
Official research evidence notes that in some patients, the pressure-lowering effect may diminish over time. This phenomenon is sometimes referred to as tachyphylaxis. If the expected pressure reduction is lost or not achieved, the patient's prescribing health professional typically reviews the course of treatment.
Q: What are the ingredients that are inactive in the Alphagan formulation?
The inactive ingredients are included to maintain the stability and consistency of the eye drop solution. These typically include a buffer system (such as sodium borate and boric acid) and various salts (sodium chloride, potassium chloride, calcium chloride, and magnesium chloride), as noted in regulatory filings.
Q: Can using too much Alphagan cause additional side effects?
Yes, regulatory documents note that excessive use, whether topical or through accidental oral ingestion, can result in signs of systemic overdose. These effects may include low blood pressure (hypotension), slow heart rate (bradycardia), and severe central nervous system depression (somnolence).
Q: What percentage of people report experiencing eye irritation with Alphagan?
Official tables from clinical trials indicate that common ocular (eye) adverse events, such as allergic conjunctivitis (eye allergy), redness of the eye, and eye itching, were reported in a significant portion of patients. Specifically, these events were reported in approximately 10% to 20% of the individuals studied.
Q: Is it true that some versions of Alphagan use a disappearing preservative?
The product Alphagan P contains a specific type of preservative called Purite®. This preservative is considered an oxidizing preservative that is designed to convert into natural components of the tears, like water and salt, once it comes into contact with the eye, which may help diminish its effect on the ocular surface.
Q: Are there any restrictions on driving or operating machinery while using Alphagan?
Alphagan may cause side effects such as drowsiness, fatigue, or blurred vision. Official labeling advises caution with activities like driving or operating machinery because the medication may cause these visual or systemic effects.
Q: Does Alphagan interact with common over-the-counter medications?
Official regulatory advice cautions against using Alphagan alongside any medicine that can potentially lower blood pressure or cause sedation/drowsiness. This warning is due to the potential for the combined effect of the medications to increase side effects.
Q: Does my diet or lifestyle affect how Alphagan works?
Regulatory information specifically highlights alcohol consumption as a lifestyle factor requiring caution. Official information states this warning is due to the potential for the risk of certain side effects, particularly those affecting the central nervous system like sedation and lightheadedness, to increase.
Q: Is there a maximum amount of time Alphagan is approved for use?
Alphagan is indicated for the treatment of elevated eye pressure. Regulatory labeling does not state a specific, defined maximum duration of treatment for its use in managing eye pressure.
Q: What are the signs of an allergic reaction to Alphagan?
Common signs of an ocular allergic reaction include eye pruritus (itching), redness of the eye, and swelling of the eye surface. Signs of a severe systemic allergic reaction may include swelling of the face, difficulty breathing, rash, hives, or syncope (fainting), as noted in post-marketing surveillance.
Q: Why is the shelf life of Alphagan drops mentioned on the packaging?
The shelf life and storage conditions are defined and mandated by regulatory agencies. This is done to ensure the product remains sterile and that the active ingredient's stability and therapeutic effectiveness are reliably maintained until the printed expiry date.
Q: Are there different concentrations of Alphagan drops available?
Yes, the active ingredient, brimonidine tartrate ophthalmic solution, is available in different prescription strengths. These include concentrations of 0.1%, 0.15% (often Alphagan P), and the original 0.2% strength.
Q: What is the general expected duration of action for one dose of Alphagan?
Official regulatory documents indicate a typical dosing frequency of three times daily, spaced approximately 8 hours apart. This frequency is based on the therapeutic duration of action for the medication.
Q: Does Alphagan contain any preservatives like benzalkonium chloride (BAK)?
The original Alphagan (0.2%) formulation contains the preservative benzalkonium chloride (BAK). However, the product Alphagan P was formulated to use the preservative Purite® as an alternative to BAK.
Q: Is Alphagan used for all types of glaucoma?
Official documentation indicates that Alphagan is specifically approved for reducing elevated fluid pressure inside the eye in patients with open-angle glaucoma or ocular hypertension. It is not broadly indicated for all different types of glaucoma conditions.
Q: How does Alphagan compare to other types of eye pressure-lowering drops, generally speaking?
Clinical trials summarized in regulatory documents compared Alphagan to other ocular pressure-lowering agents, such as timolol. These studies indicated that Alphagan's efficacy in reducing intraocular pressure was generally similar to that of these comparator drugs when administered twice daily.
Q: Why is it important to wait before putting contact lenses back in after using the drops?
Soft contact lenses must be removed before the drop is applied because the preservative, such as benzalkonium chloride, can be absorbed by the lens material. Official instructions require that lenses not be reinserted for at least 15 minutes after instillation to prevent this absorption.
Q: How does the action of Alphagan differ from other prostaglandin analogs?
Alphagan, which is an alpha-2 adrenergic agonist, works mainly by reducing the rate at which internal eye fluid (aqueous humor) is produced. In contrast, prostaglandin analogs work primarily by significantly increasing the drainage of this fluid from the eye.
